Status:
COMPLETED
Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata
Lead Sponsor:
University of Colorado, Denver
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Parkinson's Disease (PD) is a movement disorder causing either uncontrolled movement, slowness of movement, slowness of initiation of movement or rigidity of muscles. Deep Brain Stimulation (DBS) is t...
Detailed Description
Parkinson's Disease (PD) is a movement disorder causing either uncontrolled movement, slowness of movement, slowness of initiation of movement or rigidity of muscles. One method of easing PD symptoms ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Parkinson's disease
- must be able to undergo awake surgery DBS
- must have unaided vision to view visual motor task
Exclusion
- corrective eyeglasses or contact lenses
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 22 2021
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT02216435
Start Date
July 1 2014
End Date
February 22 2021
Last Update
February 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045